This filing is a standard insider initial ownership report with no trading signal. Monitor for future insider transactions or IPO-related filings that may provide material information.
Price Chart
Executive Summary
Executive Chairman Yishan Peter Li filed a Form 3 initial statement of beneficial ownership for BlossomHill Therapeutics, disclosing direct and indirect holdings including common stock and convertible preferred shares. This is a routine regulatory filing required upon becoming an insider and contains no material financial or operational information.
Key Facts
- Yishan Peter Li, Executive Chairman of BlossomHill Therapeutics, filed Form 3 on August 6, 2026.
- Direct holdings: 1,067,121 shares of common stock.
- Indirect holdings: 1,067,121 shares by spouse; 1,600,682 shares via The Li and Cui Family Trust (convertible from Series Angel Preferred); 124,779 shares via RongShan, LLC (convertible from Series B Preferred); 113,435 shares via The Li and Cui Family Trust (convertible from Series B Preferred).
- Preferred shares (Series Angel and Series B) are convertible 1:1 into common stock upon closing of the issuer's IPO.
Financial Impact
No financial impact; routine ownership disclosure.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001772233-26-000004 |
| Document: 0001772233-26-000004-index-headers.html | 0001772233-26-000004 |
| Document: 0001772233-26-000004-index.html | 0001772233-26-000004 |
| Document: 0001772233-26-000004.txt | 0001772233-26-000004 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 29d ago | Press Release | $21.34 $16.39 | ▲ +23.20% | ▲ +23.16% | $15.76 (+26.15%) |
Sep 18, 2026 5w ago | 8-K | $25.74 $13.94 | ▲ +45.84% | ▲ +46.05% | $15.76 (+38.77%) |
Sep 18, 2026 5w ago | Press Release | $25.74 $13.94 | ▼ −45.84% | ▼ −46.05% | $15.76 (−38.77%) |
Sep 15, 2026 6w ago | 8-K | $22.17 $15.48 | ▼ −30.18% | ▼ −33.15% | $15.76 (−28.91%) |
Aug 12, 2026 10w ago | Insider Cluster | $16.35 $20.86 | ▲ +27.58% | ▲ +29.33% | $15.76 (−3.61%) |
Aug 10, 2026 11w ago | Insider Cluster | $16.52 $22.00 | ▲ +33.17% | ▲ +34.23% | $15.76 (−4.60%) |
Aug 10, 2026 11w ago | 8-K | $16.52 $22.00 | ▲ +33.17% | ▲ +34.23% | $15.76 (−4.60%) |
Aug 7, 2026 11w ago | 424B4 | $15.99 $22.93 | ▲ +43.40% | ▲ +44.32% | $15.76 (−1.44%) |
Aug 7, 2026 11w ago | EFFECT | $16.00 $22.01 | ▲ +37.56% | ▲ +37.96% | $15.76 (−1.50%) |
Aug 6, 2026 11w ago | 3 | $16.00 $22.01 | ▲ +37.56% | ▲ +37.96% | $15.76 (−1.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers